26 results
8-K
EX-10.1
AXLA
Axcella Health Inc.
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
(i) contests the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling of any Pharmaceutical
8-K
EX-10.1
AXLA
Axcella Health Inc.
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling of any Pharmaceutical Product, (ii) requests the recall
8-K
EX-10.1
ekeu4vbuviwgnz3luq3u
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
10-K
mrmnpp3xx1v278
23 Mar 20
Annual report
4:12pm
10-Q
a3yu57q1qaym o8nn
20 Jun 19
Quarterly report
5:03pm
424B4
kah5cj4x53bx8 g0
9 May 19
Prospectus supplement with pricing info
4:29pm